Plans to build a long-promised biological manufacturing facility in Manhattan have fizzled, though company leaders prefer not ...

Both companies are also exploring a potential commercial-scale manufacturing agreement, reinforcing Scorpius's role as a reliable biomanufacturing partner. KaloCyte is advancing towards clinical ...

Aims to accelerate the lead candidate’s journey toward clinical success and expand its reach to patients who need it.

“This collaboration reinforces Scorpius’ reputation as a trusted and innovative biomanufacturing partner,” said Jeff Wolf, CEO of Scorpius. “ErythroMer™ is a groundbreaking advancement ...

With an experienced team and new, purpose-built U.S. facilities, Scorpius is dedicated to transparent collaboration and flexible, high-quality biologics biomanufacturing. For more information ...

The recently implemented measures include the divestiture of certain non-core assets and the initiation of programs designed to optimize operational efficien Agreement reinforces Scorpius' position as ...

“This collaboration reinforces Scorpius’ reputation as a trusted and innovative biomanufacturing partner,” said Jeff Wolf, CEO of Scorpius. “ErythroMer™ is a groundbreaking advancement that addresses ...

DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development ...

“This collaboration reinforces Scorpius’ reputation as a trusted and innovative biomanufacturing partner,” said Jeff Wolf, CEO of Scorpius. “ErythroMer™ is a ...

Morningstar brands and products Company Portfolio ...